Survey of colleges and schools of pharmacy to determine restrictions for teaching, research, and advocacy related to contraception.

Autor: Bartelme KM; Department of Pharmacy Practice, Concordia University Wisconsin School of Pharmacy, 12800 North Lake Shore Road, Mequon, WI 53097, United States. Electronic address: kassandra.bartelme@cuw.edu., Cieri-Hutcherson NE; Department of Pharmacy Practice, University at Buffalo School of Pharmacy and Pharmaceutical Sciences, 217 Pharmacy Building, Buffalo, NY 14214, United States. Electronic address: necieri@buffalo.edu., Anderson L; Oregon State University College of Pharmacy, 1601 SW Jefferson Street, Corvallis, OR 97331, United States. Electronic address: lorinda.anderson@oregonstate.edu., Barnes KN; Division of Pharmacy Practice and Administration, University of Missouri - Kansas City School of Pharmacy, 2464 Charlotte Street, Kansas City, MO 64108, United States. Electronic address: barneskn@umkc.edu., Karaoui LR; Assistant Dean for Student Affairs, Director of Experiential Education, Lebanese American University School of Pharmacy, P.O. Box 36 S 23, Byblos, Lebanon. Electronic address: lamis.karaoui@lau.edu.lb., Meredith AH; Department of Pharmacy Practice, Purdue University, 575 Stadium Mall Drive, West Lafayette, IN 47907, United States. Electronic address: ahmeredith@purdue.edu.
Jazyk: angličtina
Zdroj: Currents in pharmacy teaching & learning [Curr Pharm Teach Learn] 2023 Jun; Vol. 15 (6), pp. 551-558. Date of Electronic Publication: 2023 Jun 23.
DOI: 10.1016/j.cptl.2023.06.002
Abstrakt: Introduction: The pharmacist's role in reproductive health is evolving. Since 46 states allow providers to refuse to provide reproductive health services, it is important to consider whether learning is impacted by institution restrictions on contraception teaching, advocacy, and research.
Methods: An electronic survey was emailed to deans of all pharmacy schools on the American Association of Colleges of Pharmacy Institutional Membership list with a request to share with faculty teaching women's health content within their curriculum. The survey collected information about contraception teaching, research, and advocacy.
Results: Of 145 schools contacted, 39 (27%) provided complete responses. Of these, 22 (56%) were public, not religiously-affiliated, seven (18%) were private, not religiously-affiliated, six (15%) were private, currently religiously-affiliated, and four were (10%) private, historically religiously-affiliated. All respondents taught hormonal contraception in the required curriculum and 15 (39%) taught miscarriage management/abortifacients. None reported restrictions on contraception teaching or research. One respondent cited an advocacy restriction for contraception methods due to violation of the school's beliefs, and another cited an advocacy restriction for miscarriage management/abortifacients. Respondents noted students expressed ethical questions/concerns about refusing to dispense contraception (59%), dispensing certain contraceptives (54%), dispensing to minors (46%), and dispensing all contraceptives (21%). Additionally, respondents reported pharmacists/faculty expressed ethical questions/concerns about refusing to dispense contraception (31%), dispensing to minors (21%), dispensing certain contraceptives (15%), and all contraceptives (13%).
Conclusions: Overall, respondents reported no restrictions in contraception teaching and scholarship and minimal advocacy restrictions. Faculty should consider ethical questions/concerns from students, faculty, and pharmacists when teaching this material.
Competing Interests: Declaration of Competing Interest None.
(Copyright © 2023 Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: